As some clinical studies indicated, ambiguous results that exist with the APN level showing a decrease, increase, or no significant changes in AD patients (Dukic et al., 2016; Gorska‐Ciebiada et al., 2016; Khemka et al., 2014). This evidence concerns the gene ANPEP and Alzheimer disease.